JNCE - Jounce Therapeutics, Inc. - SEC Form 4 Insider Trading Screener

Manufactured Goods - Chemicals - Biological Products, (No Diagnostic Substances) - JNCE (1640455)
General
Tickers
Insider
Sh Price $
Lqdty M$
Date
Filing Date
  
Trade Date
  
Filing Delay
N Days Ago
Transaction Filing
 P - Purchase
 S - Sale
 A - Grant
 D - Sale to Iss
 G - Gift
 F - Tax
 M - Option Ex
 X - Option Ex
 C - Cnv Deriv
 W - Inherited
No deriv Multiple Days
Traded K$
Own Chg %
Industry
Insider Title     Officer
    COB
    CEO
    Pres
    COO
    CFO
    GC
    VP
  Director
  10%own
  Other
Group by
Sort by
Max Results
Page
   clear
6 results. Finviz - SEC - Yahoo - Stockcharts - Tradingview
TCcnt1d1w1m6m

X

Filing Date

Trade Date

Ticker

Insider Name

Title

Trade Type  

Price

Qty

Owned

ΔOwn

Value

1d

1w

1m

6m

2023-04-04
JNCEMurray Richard /Ca/DirS - Sale$1.85-39,228188,779-17%-$72,572
M
2023-03-13
JNCETang Kevin C10%P - Purchase$1.00+85,9875,300,087+2%+$85,958
M
2023-01-09
JNCETrehu ElizabethChief Medical OfficerS - Sale$1.11-9,285103,417-8%-$10,316
M
2023-01-09
JNCEMurray Richard /ca/CEO, PresS - Sale$1.11-45,070228,007-17%-$50,075
M
2023-01-09
JNCEDrapkin Kimberlee CCFO, TreasurerS - Sale$1.11-14,09666,018-18%-$15,661
M
2023-01-09
JNCECole Hugh MCOOS - Sale$1.11-16,634110,082-13%-$18,481

AAmended filing
DDerivative transaction in filing (usually option exercise)
EError detected in filing
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top